Insider transactions

EDGAR

Protalix BioTherapeutics, Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-17.

Open-market purchases (code P)
1 transactions, 56,000 shares
Sum of shares × price per share: 101,360
Open-market sales (code S)
1 transactions, 168 shares
Sum of shares × price per share: 314.16

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–20 of 20

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-09-03 Filed 2026-09-09Schwartz Aharon Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Options (Right to Buy) — underlying Common Stock (17,000) — exercise price 2.59
Acquired (A)17,0000—17,000Direct (D) No
F1, F2
  • F1 The shares of common stock underlying the stock options vest in 12 equal quarterly installments commencing upon the date of grant.
  • F2 Does not include (i) options to purchase 40,000 shares of common stock at an exercise price equal to $3.55 per share that expire on January 20, 2030, (ii) options to purchase 50,000 shares of common stock at an exercise price equal to $1.03 per share that expire on September 7, 2032, (iii) options to purchase 61,676 shares of common stock at an exercise price equal to $1.66 per share that expire on September 29, 2033 and (iv) options to purchase 15,000 shares of common stock at an exercise price equal to $1.64 per share that expire on September 3, 2035.
Open filing 0001178913-26-004471 Read from the filing’s XML Dispute this row
2026-09-03 Filed 2026-09-09Schwartz Aharon Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units — underlying Common Stock (8,500)
Acquired (A)8,5000—8,500Direct (D) No
F3, F4
  • F3 Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of the Isuer's common stock.
  • F4 The shares of common stock underlying the RSUs vest in 12 equal quarterly installments commencing upon the date of grant.
Open filing 0001178913-26-004471 Read from the filing’s XML Dispute this row
2026-09-03 Filed 2026-09-04Forster Eliot Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Options (Right to Buy) — underlying Common Stock (17,000) — exercise price 2.59
Acquired (A)17,0000—17,000Direct (D) No
F1, F2
  • F1 The shares of common stock underlying the stock options vest in 12 equal quarterly installments commencing upon the date of grant.
  • F2 Does not include (i) options to purchase 85,715 shares of common stock at an exercise price equal to $1.75 per share that expire on September 14, 2033, and (ii) options to purchase 15,000 shares of common stock at an exercise price equal to $1.64 per share that expire on September 3, 2035.
Open filing 0001831558-26-000003 Read from the filing’s XML Dispute this row
2026-09-03 Filed 2026-09-04Forster Eliot Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units — underlying Common Stock (8,500)
Acquired (A)8,5000—8,500Direct (D) No
F3, F4
  • F3 Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of the Isuer's common stock.
  • F4 The shares of common stock underlying the RSUs vest in 12 equal quarterly installments commencing upon the date of grant.
Open filing 0001831558-26-000003 Read from the filing’s XML Dispute this row
2026-09-03 Filed 2026-09-04Ben Zvi Shmuel Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Options (Right to Buy) — underlying Common Stock (17,000) — exercise price 2.59
Acquired (A)17,0000—17,000Direct (D) No
F1, F2
  • F1 The shares of common stock underlying the stock options vest in 12 equal quarterly installments commencing upon the date of grant.
  • F2 Does not include (i) options to purchase 40,000 shares of common stock at an exercise price equal to $1.09 per share that expire on June 30, 2032, (ii) options to purchase 10,000 shares of common stock at an exercise price equal to $1.03 per share that expire on September 7, 2032, (iii) options to purchase 61,676 shares of common stock at an exercise price equal to $1.66 per share that expire on September 29, 2033, and (iv) options to purchase 15,000 shares of common stock at an exercise price equal to $1.64 per share that expire on September 3, 2035.
Open filing 0001935668-26-000002 Read from the filing’s XML Dispute this row
2026-09-03 Filed 2026-09-04Ben Zvi Shmuel Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units — underlying Common Stock (8,500)
Acquired (A)8,5000—8,500Direct (D) No
F3, F4
  • F3 Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of the Isuer's common stock.
  • F4 The shares of common stock underlying the RSUs vest in 12 equal quarterly installments commencing upon the date of grant.
Open filing 0001935668-26-000002 Read from the filing’s XML Dispute this row
2026-09-03 Filed 2026-09-04Naos Yaron Officer: Sr. VP COO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (112,000) — exercise price 2.59
Acquired (A)112,0000—112,000Direct (D) No
F1, F2
  • F1 The shares of common stock underlying the stock options vest in 12 equal quarterly installments commencing upon the date of grant.
  • F2 Does not include (i) options to purchase 60,000 shares of common stock at an exercise price equal to $5.60 per share that expire on September 13, 2028, (ii) options to purchase 122,656 shares of common stock at an exercise price equal to $3.59 per share that expire on August 11, 2030 (iii) options to purchase 340,000 shares of common stock at an exercise price equal to $1.03 per share that expire on September 7, 2032, (iv) options to purchase 100,000 shares of common stock at an exercise price equal to $1.10 per share that expire on September 23, 2034, and (v) options to purchase 50,000 shares of common stock at an exercise price equal to $1.64 per share that expire on September 3, 2035.
Open filing 0001742727-26-000002 Read from the filing’s XML Dispute this row
2026-09-03 Filed 2026-09-04Naos Yaron Officer: Sr. VP COO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units — underlying Common Stock (56,000)
Acquired (A)56,0000—56,000Direct (D) No
F3, F4
  • F3 Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of the Isuer's common stock.
  • F4 The shares of common stock underlying the RSUs vest in 12 equal quarterly installments commencing upon the date of grant.
Open filing 0001742727-26-000002 Read from the filing’s XML Dispute this row
2026-09-03 Filed 2026-09-04Bar-Shalev Amos Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Options (Right to Buy) — underlying Common Stock (17,000) — exercise price 2.59
Acquired (A)17,0000—17,000Direct (D) No
F1, F2
  • F1 The shares of common stock underlying the stock options vest in 12 equal quarterly installments commencing upon the date of grant.
  • F2 Does not include (i) options to purchase 40,000 shares of common stock at an exercise price equal to $3.55 per share that expire on January 20, 2030, (ii) options to purchase 50,000 shares of common stock at an exercise price equal to $1.03 per share that expire on September 7, 2032, (iii) options to purchase 61,676 shares of common stock at an exercise price equal to $1.66 per share that expire on September 29, 2033, and (iv) options to purchase 15,000 shares of common stock at an exercise price equal to $1.64 per share that expire on September 3, 2035.
Open filing 0001385113-26-000002 Read from the filing’s XML Dispute this row
2026-09-03 Filed 2026-09-04Bar-Shalev Amos Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units — underlying Common Stock (8,500)
Acquired (A)8,5000—8,500Direct (D) No
F3, F4
  • F3 Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of the Isuer's common stock.
  • F4 The shares of common stock underlying the RSUs vest in 12 equal quarterly installments commencing upon the date of grant.
Open filing 0001385113-26-000002 Read from the filing’s XML Dispute this row
2026-09-03 Filed 2026-09-04Boudes Pol F Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Options (Right to Buy) — underlying Common Stock (17,000) — exercise price 2.59
Acquired (A)17,0000—17,000Direct (D) No
F1, F2
  • F1 The shares of common stock underlying the stock options vest in 12 equal quarterly installments commencing upon the date of grant.
  • F2 Does not include (i) options to purchase 40,000 shares of common stock at an exercise price equal to $3.55 per share that expire on January 20, 2030, (ii) options to purchase 50,000 shares of common stock at an exercise price equal to $1.03 per share that expire on September 7, 2032, (iii) options to purchase 61,676 shares of common stock at an exercise price equal to $1.66 per share that expire on September 29, 2033, and (iv) options to purchase 15,000 shares of common stock at an exercise price equal to $1.64 per share that expire on September 3, 2035.
Open filing 0001454771-26-000002 Read from the filing’s XML Dispute this row
2026-09-03 Filed 2026-09-04Boudes Pol F Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units — underlying Common Stock (8,500)
Acquired (A)8,5000—8,500Direct (D) No
F3, F4
  • F3 Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of the Isuer's common stock.
  • F4 The shares of common stock underlying the RSUs vest in 12 equal quarterly installments commencing upon the date of grant.
Open filing 0001454771-26-000002 Read from the filing’s XML Dispute this row
2026-09-03 Filed 2026-09-04Melincoff Gwen A Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Options (Right to Buy) — underlying Common Stock (17,000) — exercise price 2.59
Acquired (A)17,0000—17,000Direct (D) No
F1, F2
  • F1 The shares of common stock underlying the stock options vest in 12 equal quarterly installments commencing upon the date of grant.
  • F2 Does not include (i) options to purchase 40,000 shares of common stock at an exercise price equal to $3.55 per share that expire on January 20, 2030, (ii) options to purchase 50,000 shares of common stock at an exercise price equal to $1.03 per share that expire on September 7, 2032, (iii) options to purchase 61,676 shares of common stock at an exercise price equal to $1.66 per share that expire on September 29, 2033 and (iv) options to purchase 15,000 shares of common stock at an exercise price equal to $1.64 per share that expire on September 3, 2035.
Open filing 0001614890-26-000002 Read from the filing’s XML Dispute this row
2026-09-03 Filed 2026-09-04Melincoff Gwen A Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units — underlying Common Stock (8,500)
Acquired (A)8,5000—8,500Direct (D) No
F3, F4
  • F3 Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of the Isuer's common stock.
  • F4 The shares of common stock underlying the RSUs vest in 12 equal quarterly installments commencing upon the date of grant.
Open filing 0001614890-26-000002 Read from the filing’s XML Dispute this row
2026-09-03 Filed 2026-09-04Elze Christian Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Options (Right to Buy) — underlying Common Stock (17,000) — exercise price 2.59
Acquired (A)17,0000—17,000Direct (D) No
F1, F2
  • F1 The shares of common stock underlying the stock options vest in 12 equal quarterly installments commencing upon the date of grant.
  • F2 Does not include options to purchase 15,000 shares of common stock at an exercise price equal to $1.64 per share that expire on September 3, 2035.
Open filing 0002075661-26-000002 Read from the filing’s XML Dispute this row
2026-09-03 Filed 2026-09-04Elze Christian Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units — underlying Common Stock (8,500)
Acquired (A)8,5000—8,500Direct (D) No
F3, F4
  • F3 Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of the Isuer's common stock.
  • F4 The shares of common stock underlying the RSUs vest in 12 equal quarterly installments commencing upon the date of grant.
Open filing 0002075661-26-000002 Read from the filing’s XML Dispute this row
2026-09-03 Filed 2026-09-04Bashan Dror Director · Officer: PRESIDENT AND CEO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (320,000) — exercise price 2.59
Acquired (A)320,0000—320,000Direct (D) No
F1, F2
  • F1 The shares of common stock underlying the stock options vest in 12 equal quarterly installments commencing upon the date of grant. The stock options are subject to accelerated vesting upon a corporate transaction or a change in control as described in the Protalix BioTherapeutics, Inc., Amended and Restated 2006 Stock Incentive Plan.
  • F2 Does not include (i) options to purchase 160,000 shares of common stock at an exercise price equal to $4.69 per share that expire on June 30, 2029, (ii) options to purchase 750,000 shares of common stock at an exercise price equal to $1.03 per share that expire on September 7, 2032 and (iii) options to purchase 340,000 shares of common stock at an exercise price equal to $1.64 per share that expire on September 3, 2035.
Open filing 0001781450-26-000002 Read from the filing’s XML Dispute this row
2026-09-03 Filed 2026-09-04Bashan Dror Director · Officer: PRESIDENT AND CEO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Units — underlying Common Stock (160,000)
Acquired (A)160,0000—160,000Direct (D) No
F3, F4
  • F3 Each restricted stock unit (RSU) represents the right to receive, following vesting, one share of the Isuer's common stock.
  • F4 The shares of common stock underlying the RSUs vest in 12 equal quarterly installments commencing upon the date of grant.
Open filing 0001781450-26-000002 Read from the filing’s XML Dispute this row
2025-12-19 Filed 2025-12-23Bashan Dror Director · Officer: PRESIDENT AND CEO
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)56,0001.81
101,360

Derived: shares × price per share. Exact value 101360.00.

188,516Direct (D) No— Open filing 0001781450-25-000005 Read from the filing’s XML Dispute this row
2025-11-18 Filed 2025-11-19Bar-Shalev Amos Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1681.87
314.16

Derived: shares × price per share. Exact value 314.16.

0Direct (D) No— Open filing 0001385113-25-000005 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 7,211 filings read, the latest filed 2026-11-13. Prior quarter ending 2026-06-30: 9,150 filings read.

Showing 1–50 of 81

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
BlackRock, Inc. Partly reported under another manager4,200,737 SH11,594,034 dollarsHigher by 154,087 Prior quarter: 4,046,650Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
STATE STREET CORP Partly reported under another manager1,157,119 SH3,193,648 dollarsHigher by 173,537 Prior quarter: 983,582Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager997,128 SH2,752,072 dollarsHigher by 17,133 Prior quarter: 979,995Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
RENAISSANCE TECHNOLOGIES LLC Partly reported under another manager988,100 SH2,727,156 dollarsLower by 107,900 Prior quarter: 1,096,000Open filing 0001037389-26-000062 Filed 2026-11-12 Dispute this row
DIMENSIONAL FUND ADVISORS LP Partly reported under another manager716,986 SH1,978,213 dollarsHigher by 223,562 Prior quarter: 493,424Open filing 0000354204-26-001096 Filed 2026-11-04 Dispute this row
VANGUARD PORTFOLIO MANAGEMENT LLC 557,199 SH1,537,869 dollarsHigher by 46,560 Prior quarter: 510,639Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row
Stratos Wealth Partners, LTD. 400,000 SH1,104,000 dollarsLower by 100,000 Prior quarter: 500,000Open filing 0001612865-26-000006 Filed 2026-11-13 Dispute this row
Creative Planning 375,359 SH1,035,991 dollarsNot in the prior quarter’s filings read Open filing 0001540235-26-000006 Filed 2026-11-02 Dispute this row
STRS OHIO 332,500 SH917,700 dollarsHigher by 36,400 Prior quarter: 296,100Open filing 0000820478-26-000018 Filed 2026-10-30 Dispute this row
ACADIAN ASSET MANAGEMENT LLC Partly reported under another manager331,946 SH913 dollarsNot in the prior quarter’s filings read Open filing 0001140361-26-042753 Filed 2026-11-09 Dispute this row
MARSHALL WACE, LLP Partly reported under another manager301,768 SH832,880 dollarsLower by 150,989 Prior quarter: 452,757Open filing 0001318757-26-000012 Filed 2026-11-13 Dispute this row
GROUP ONE TRADING LLC Option: Call 274,200 SH756,792 dollarsHigher by 199,500 Prior quarter: 74,700Open filing 0000932540-26-000017 Filed 2026-11-10 Dispute this row
Russell Investments Group, Ltd. Partly reported under another manager248,557 SH686,016 dollarsHigher by 223,792 Prior quarter: 24,765Open filing 0001193125-26-451241 Filed 2026-11-06 Dispute this row
Bank of New York Mellon Corp Partly reported under another manager231,814 SH639,807 dollarsLower by 1,178 Prior quarter: 232,992Open filing 0001390777-26-000121 Filed 2026-11-05 Dispute this row
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP Partly reported under another manager163,881 SH452,312 dollarsNot in the prior quarter’s filings read Open filing 0001164508-26-000060 Filed 2026-11-13 Dispute this row
Concurrent Investment Advisors, LLC 126,314 SH348,627 dollarsNot in the prior quarter’s filings read Open filing 0002085853-26-001211 Filed 2026-10-16 Dispute this row
Nuveen, LLC Partly reported under another manager98,593 SH272,117 dollarsHigher by 8,405 Prior quarter: 90,188Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row
Empowered Funds, LLC Partly reported under another manager98,344 SH271,429 dollarsNot in the prior quarter’s filings read Open filing 0001592828-26-000008 Filed 2026-11-13 Dispute this row
MORGAN STANLEY Partly reported under another manager97,585 SH269,334 dollarsHigher by 45,909 Prior quarter: 51,676Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
Quadrature Capital Ltd Partly reported under another manager77,751 SH214,593 dollarsNot in the prior quarter’s filings read Open filing 0001651424-26-000014 Filed 2026-11-13 Dispute this row
VANGUARD FIDUCIARY TRUST CO 73,495 SH202,846 dollarsHigher by 3,218 Prior quarter: 70,277Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
Walleye Capital LLC 70,533 SH194,671 dollarsHigher by 50,694 Prior quarter: 19,839Open filing 0001758720-26-000007 Filed 2026-11-13 Dispute this row
DEUTSCHE BANK AG\ Partly reported under another manager67,954 SH187,553 dollarsLower by 9,583 Prior quarter: 77,537Open filing 0000948046-26-000083 Filed 2026-11-06 Dispute this row
BAILARD, INC. 61,100 SH168,636 dollarsUnchanged Prior quarter: 61,100Open filing 0001172661-26-004508 Filed 2026-10-13 Dispute this row
WINTON GROUP Ltd 54,403 SH150,152 dollarsLower by 1,598 Prior quarter: 56,001Open filing 0001612063-26-000014 Filed 2026-11-12 Dispute this row
RHUMBLINE ADVISERS 47,580 SH131,315 dollarsHigher by 1,356 Prior quarter: 46,224Open filing 0001115418-26-000015 Filed 2026-11-10 Dispute this row
JPMORGAN CHASE CO Partly reported under another manager40,133 SH107,958 dollarsLower by 92,858 Prior quarter: 132,991Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row
JANE STREET GROUP, LLC Option: Call Partly reported under another manager39,200 SH108,192 dollarsLower by 100 Prior quarter: 39,300Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row
FRANKLIN TEMPLETON INC Partly reported under another manager39,077 SH105,117 dollarsLower by 2,237 Prior quarter: 41,314Open filing 0000038777-26-000291 Filed 2026-11-12 Dispute this row
Invesco Ltd. Partly reported under another manager39,053 SH107,786 dollarsHigher by 2,337 Prior quarter: 36,716Open filing 0000914208-26-000462 Filed 2026-11-12 Dispute this row
Cambridge Investment Research Advisors, Inc. 37,812 SH104 dollarsNot in the prior quarter’s filings read Open filing 0001419186-26-000008 Filed 2026-11-02 Dispute this row
BARCLAYS PLC Partly reported under another manager31,938 SH88,149 dollarsHigher by 20,448 Prior quarter: 11,490Open filing 0000312069-26-000241 Filed 2026-11-06 Dispute this row
BOLTON SECURITIES CORPORATION 31,060 SH85,726 dollarsUnchanged Prior quarter: 31,060Open filing 0001457457-26-000016 Filed 2026-11-12 Dispute this row
Aptus Capital Advisors, LLC 28,612 SH78,969 dollarsHigher by 646 Prior quarter: 27,966Open filing 0001398344-26-020003 Filed 2026-11-13 Dispute this row
SIMPLEX TRADING, LLC Option: Call 27,100 SH74,796 dollarsHigher by 16,400 Prior quarter: 10,700Open filing 0001488542-26-000013 Filed 2026-11-04 Dispute this row
Smartleaf Asset Management LLC 25,975 SH69,873 dollarsUnchanged Prior quarter: 25,975Open filing 0002010393-26-000006 Filed 2026-11-10 Dispute this row
EARNED WEALTH ADVISORS, LLC 25,975 SH71,691 dollarsUnchanged Prior quarter: 25,975Open filing 0001905663-26-000008 Filed 2026-11-06 Dispute this row
State of Alaska, Department of Revenue 21,831 SH60 dollarsUnchanged Prior quarter: 21,831Open filing 0001370102-26-000011 Filed 2026-10-15 Dispute this row
BNP PARIBAS FINANCIAL MARKETS Partly reported under another manager20,730 SH57,215 dollarsHigher by 8,066 Prior quarter: 12,664Open filing 0001166588-26-000012 Filed 2026-11-12 Dispute this row
COMMONWEALTH EQUITY SERVICES, LLC Partly reported under another manager19,461 SH53,710 dollarsUnchanged Prior quarter: 19,461Open filing 0000312272-26-000024 Filed 2026-11-02 Dispute this row
Police Firemen's Retirement System of New Jersey Partly reported under another manager18,554 SH51,209 dollarsUnchanged Prior quarter: 18,554Open filing 0002040686-26-000007 Filed 2026-11-09 Dispute this row
VOYA INVESTMENT MANAGEMENT LLC Partly reported under another manager16,634 SH45,910 dollarsHigher by 5,917 Prior quarter: 10,717Open filing 0001068837-26-000006 Filed 2026-11-10 Dispute this row
SIMPLEX TRADING, LLC Option: Put 16,400 SH45,263 dollarsLower by 11,400 Prior quarter: 27,800Open filing 0001488542-26-000013 Filed 2026-11-04 Dispute this row
Ashton Thomas Private Wealth, LLC 15,828 SH43,685 dollarsNot in the prior quarter’s filings read Open filing 0001398344-26-019316 Filed 2026-11-03 Dispute this row
GROUP ONE TRADING LLC Option: Put 15,700 SH43,332 dollarsHigher by 300 Prior quarter: 15,400Open filing 0000932540-26-000017 Filed 2026-11-10 Dispute this row
Lido Advisors, LLC 15,554 SH42,929 dollarsLower by 6 Prior quarter: 15,560Open filing 0001172661-26-004854 Filed 2026-11-04 Dispute this row
AMERICAN CENTURY COMPANIES INC Partly reported under another manager15,523 SH42,843 dollarsNot in the prior quarter’s filings read Open filing 0000748054-26-000008 Filed 2026-11-12 Dispute this row
JANE STREET GROUP, LLC Option: Put Partly reported under another manager15,400 SH42,504 dollarsLower by 21,500 Prior quarter: 36,900Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row
UBS Group AG Partly reported under another manager12,741 SH35,165 dollarsLower by 125,905 Prior quarter: 138,646Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
Spark Investment Management LLC 11,800 SH32,568 dollarsNot in the prior quarter’s filings read Open filing 0000899140-26-001312 Filed 2026-11-13 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • NORTHERN TRUST CORP 922,340 SH
  • GOLDMAN SACHS GROUP INC 475,922 SH
  • CITADEL ADVISORS LLC 334,227 SH
  • Main Street Financial Solutions, LLC 214,100 SH
  • SUSQUEHANNA INTERNATIONAL GROUP, LLP 196,100 SH
  • BRIDGEWAY CAPITAL MANAGEMENT, LLC 189,100 SH
  • Hillsdale Investment Management Inc. 185,711 SH
  • Sixth Street Partners Management Company, L.P. 180,381 SH
  • CHARLES SCHWAB INVESTMENT MANAGEMENT INC 180,381 SH
  • MILLENNIUM MANAGEMENT LLC 171,535 SH
  • AQR CAPITAL MANAGEMENT LLC 167,826 SH
  • LAZARD ASSET MANAGEMENT LLC 165,561 SH
  • SUSQUEHANNA INTERNATIONAL GROUP, LLP 71,600 SH
  • WELLS FARGO COMPANY/MN 67,549 SH
  • State of Wyoming 59,179 SH
  • PRICE T ROWE ASSOCIATES INC /MD/ 53,478 SH
  • BANK OF AMERICA CORP /DE/ 51,896 SH
  • MetLife Investment Management, LLC 45,500 SH
  • CITADEL ADVISORS LLC 45,200 SH
  • TWO SIGMA INVESTMENTS, LP 42,515 SH
  • SUSQUEHANNA INTERNATIONAL GROUP, LLP 40,944 SH
  • Phoenix Financial Ltd. 40,000 SH
  • MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 34,097 SH
  • NEW YORK STATE COMMON RETIREMENT FUND 31,100 SH
  • Point72 Asset Management, L.P. 25,566 SH
  • ALLIANCEBERNSTEIN L.P. 24,160 SH
  • PRELUDE CAPITAL MANAGEMENT, LLC 22,700 SH
  • JANE STREET GROUP, LLC 18,020 SH
  • TWO SIGMA SECURITIES, LLC 17,795 SH
  • INTECH INVESTMENT MANAGEMENT LLC 16,446 SH
  • IEQ CAPITAL, LLC 13,774 SH
  • Equitable Holdings, Inc. 13,150 SH
  • Cascade Financial Partners, LLC 12,000 SH
  • NEUBERGER BERMAN GROUP LLC 11,580 SH
  • PRUDENTIAL FINANCIAL INC 10,110 SH
  • HARBOUR INVESTMENT MANAGEMENT LLC 10,100 SH
  • MCF Advisors LLC 10,000 SH
  • ROYAL BANK OF CANADA 9,654 SH
  • Tower Research Capital LLC (TRC) 8,669 SH
  • MERCER GLOBAL ADVISORS INC /ADV 8,639 SH
  • GROUP ONE TRADING LLC 7,872 SH
  • Legal General Group Plc 6,333 SH
  • Integrated Wealth Concepts LLC 2,793 SH
  • NATIONAL BANK OF CANADA /FI/ 2,000 SH
  • Federation des caisses Desjardins du Quebec 250 SH
  • True Wealth Design, LLC 115 SH
  • IFP Advisors, Inc 9 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
HOLD Alapkezelo Zrt. Common Shares5.24,157,791.0010/14/2026 Filed 2026-10-15SCHEDULE 13GOpen filing 0002086358-26-000006 Dispute this row
BlackRock, Inc. Common Stock5.024,046,65006/30/2026 Filed 2026-07-29SCHEDULE 13GOpen filing 0002012383-26-002863 Dispute this row
MAK Capital Fund LP Common Stock, $0.001 par value per share4.53,616,289.0003/24/2026 Filed 2026-03-30SCHEDULE 13G/AAmendment 1Open filing 0001426156-26-000006 Dispute this row
MAK CAPITAL ONE LLC Common Stock, $0.001 par value per share4.53,616,289.0003/24/2026 Filed 2026-03-30SCHEDULE 13G/AAmendment 1Open filing 0001426156-26-000006 Dispute this row
Kaufman Michael A Common Stock, $0.001 par value per share4.53,616,289.0003/24/2026 Filed 2026-03-30SCHEDULE 13G/AAmendment 1Open filing 0001426156-26-000006 Dispute this row
MAK Capital Fund LP Common Stock, $0.001 par value per share5.84,649,599.0002/26/2026 Filed 2026-03-04SCHEDULE 13GOpen filing 0001426156-26-000002 Dispute this row
MAK CAPITAL ONE LLC Common Stock, $0.001 par value per share5.84,649,599.0002/26/2026 Filed 2026-03-04SCHEDULE 13GOpen filing 0001426156-26-000002 Dispute this row
Kaufman Michael A Common Stock, $0.001 par value per share5.84,649,599.0002/26/2026 Filed 2026-03-04SCHEDULE 13GOpen filing 0001426156-26-000002 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,119,757 filings read, dated 2004-06-14 to 2026-11-13: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
20151
2016204,322
2017202,494
2018202,048
2019193,638
2020144,184
2021224,474
202242,927
2023199,811
2024209,823
2025235,520
2026254,737

Filings made before the SEC required XML are listed, not extracted.

Back to Protalix BioTherapeutics, Inc.